Pharma boom for Denmark
Industry (LIF) reveals a boom in pharmaceutical exports in 2002.
Sales totalled DK30.3 billion (€4.3 billion), an increase of
approximately DK2 billion (€268 million) compared with 2001.
Data published by the Danish Association of the Pharmaceutical Industry (LIF) reveals a boom in pharmaceutical exports in 2002. Sales totalled DK30.3 billion (€4.3 billion), an increase of approximately DK2 billion (€268 million) compared with 2001.
Danish newspaper Berlingske Tidende reports that over the last 12 years Danish medical exports have increased four-fold compared to a two-fold increase in total exports during the same period. The medical industry's contribution to total Danish exports in 2002 amounted to 7 per cent.
According to the report, the most important export markets are the US, Germany, UK, France and Sweden. Measured on both volume and growth rates, the US is by far the most significant market, exports amounting to DK4.225 billion (€567 million) in 2002, an increase of almost DK1 billion compared with 2001.
The newspaper goes on to conclude that LIF data provides concrete proof that Denmark is steadily developing its position as a knowledge society financed by research-based exports.
